Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial

NCT04881825 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: Glepaglutide

Sponsor

Zealand Pharma